Overview

A Pilot Study of TRV130 for the Treatment of Fracture Pain

Status:
Terminated
Trial end date:
2015-10-23
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.
Phase:
Phase 2
Details
Lead Sponsor:
Trevena Inc.
Collaborator:
Kestrel Biologic